Appendix 4C– June 2019 Quarter

NEXT STORY
Turning Point Therapeutics Appoints Biotechnology Investment Banker Yi Larson as Executive Vice President and Chief Financial Officer
PREV STORY
Plus Therapeutics, Inc. Announces Nasdaq Ticker Symbol Changes and Reverse Stock Split
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

VALNEVA and HOOKIPA Sign a Collaboration and Manufacturing Agreement

Valneva and HOOKIPA Sign a Collaboration and Manufacturing Agreement Saint-Herblain, France, and Vienna, Austria, ...

author_avatar
NASDAQ Market News

Sera Prognostics Collaborates with Christiana Care Health System to Launch New Preterm Birth Study with PreTRM® Test

AVERT PRETERM TRIAL studies the impact of interventions based on early risk identificationSALT LAKE ...

author_avatar
NASDAQ Market News

Helomics® Corporation and Ariel Precision Medicine, Inc. sign a services agreement to Advance Clinical Genomics in Precision Medicine Applications

PITTSBURGH, Dec. 20, 2017 (GLOBE NEWSWIRE) -- Helomics® Corporation (Helomics), a privately-held, healthcare company providing personalized medicine ...

author_avatar
NASDAQ Market News